Browsing: Banking And Finance News

The FDA’s pancreatic cancer drug approval for Revolution Medicines’ daraxonrasib lands months early, but the stock barely moved. Here’s why.

Majedie Investments (MAJE) posted a Majedie Investments NAV return of +10.7% for the quarter to…

Abbott’s Libre Duo 10 Day wins FDA authorisation as the first dual glucose-ketone sensor, opening a new front in diabetes-tech competition.

Boston Scientific cyberattack disrupts global order processing and shipping; shares fall as investigation into the breach continues.

McKesson’s Precision Medicine Group acquisition, worth ~$2.25bn, deepens its push into oncology and specialty services, filings show.

Lloyds Banking Group half-year profit rose to £4.3bn in the six months to 30 June,…

OpenAI’s data centers chief Chris Malone has left the company, the latest in a run of senior exits ahead of a planned 2027 listing.

Canada retaliatory tariffs of up to 50% hit $20bn of US goods from 8 September, matching Washington’s levies dollar-for-dollar.

The Greggs interim results 2026 sent the baker’s shares up 16.1% on 29 July, extending…

Dick’s Sporting Goods stock plunge wiped a quarter of its value after a $31.9m Foot Locker loss and a cut to full-year profit guidance.